Correction: Combined MEK and ERK inhibition overcomes therapy-mediated pathway reactivation in RAS mutant tumors.

Merchant, Mark; Moffat, John; Schaefer, Gabriele; Chan, Jocelyn; Wang, Xi; Orr, Christine; Cheng, Jason; Hunsaker, Thomas; Shao, Lily; Wang, Stephanie J; Wagle, Marie-Claire; Lin, Eva; Haverty, Peter M; Shahidi-Latham, Sheerin; Ngu, Hai; Solon, Margaret; Eastham-Anderson, Jeffrey; Koeppen, Hartmut; Huang, Shih-Min A; Schwarz, Jacob; Belvin, Marcia; Kirouac, Daniel; Junttila, Melissa R

Merchant, Mark; Moffat, John; Schaefer, Gabriele; Chan, Jocelyn; Wang, Xi; Orr, Christine; Cheng, Jason; Hunsaker, Thomas; Shao, Lily; Wang, Stephanie J; Wagle, Marie-Claire; Lin, Eva; Haverty, Peter M; Shahidi-Latham, Sheerin; Ngu, Hai; Solon, Margaret; Eastham-Anderson, Jeffrey; Koeppen, Hartmut; Huang, Shih-Min A; Schwarz, Jacob; Belvin, Marcia; Kirouac, Daniel; Junttila, Melissa R.

PLoS One ; 13(1): e0192059, 2018.

Article em En | MEDLINE | ID: mdl-29370292

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Idioma: En Revista: PLoS One Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2018 Tipo de documento: Article